Related references
Note: Only part of the references are listed.Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice
Daniel A. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The challenges posed by reemerging Clostridium difficile infection
David B. Blossom et al.
CLINICAL INFECTIOUS DISEASES (2007)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Orally administered recombinant metallo-β-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice
U Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model
SD Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Orally administered targeted recombinant beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: A novel approach to reducing antimicrobial resistance
J Harmoinen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Oral administration of β-lactamase preserves colonization resistance of piperacillin-treated mice
U Stiefel et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Share Paper
